Passage Bio, Inc. (PASG) Tops Q2 EPS by 9c

Passage Bio, Inc. (NASDAQ: PASG) reported Q2 EPS of ($0.73), $0.09 better than the analyst estimate of ($0.82).

For earnings history and earnings-related data on Passage Bio, Inc. (PASG) click here.

You May Also Be Interested In

• AI and earnings keep driving markets as focus shifts to Trump-Xi summit
• Amrize Ltd (AMRZ) PT Lowered to $42 at UBS on Lower Earnings Estimates
• Meta bull case increasingly playing out, Mizuho says